Trials / Unknown
UnknownNCT01431053
Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer
Phase 2 Study of Aspirin Plus Exemestane Comparing With Exemestane Alone in the Adjuvant Treatment of Postmenopausal Breast Cancer
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- Sponsor
- Chinese Academy of Medical Sciences · Academic / Other
- Sex
- Female
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase II study to assess efficacy/safety of Exemestane with or without Aspirin as the adjuvant treatment in postmenopausal breast cancer patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | aspirin | Aspirin 50mg po daily |
| DRUG | Exemestane | Exemestane 25mg po daily |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2011-09-09
- Last updated
- 2013-03-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01431053. Inclusion in this directory is not an endorsement.